Market Overview

BGI-Shenzhen Receives Approval from Ministry of Commerce of PRC for Proposed Acquisition Of Complete Genomics

BGI-Shenzhen ("BGI") and Complete Genomics (NASDAQ: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.

BGI and Complete are awaiting approval of the State Administration of Foreign Exchange of the People's Republic of China regarding the proposed acquisition.

BGI's financial advisor is Citi, and its legal counsel is O'Melveny & Myers LLP. Complete's financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins LLP.

Stockholders with questions about the Offer or who need assistance with tendering their shares of common stock of Complete, may call the Information Agent, Innisfree M&A Incorporated, toll-free, at (888) 750-5834.

FORWARD-LOOKING STATEMENTS

Certain statements either contained in or incorporated by reference into this document are forward-looking statements that involve risks and uncertainty. Future events regarding the proposed transactions and both BGI's and Complete's actual results could differ materially from the forward-looking statements. Factors that might cause such a difference include, but are not limited

See full press release

Posted-In: News Guidance Asset Sales Management M&A Global

 

Related Articles (GNOM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters